Can We Think Of Anything Else For the FDA To Do?

  • by: |
  • 03/08/2007
Today the Senate reintroduce legislation to require the FDA insure that packages, wholesalers and manufacturing plants in Europe -- all old drugs of course -- are safe. The bill also requires the FDA to claim that drugs with different coatings, formulations, doses but same active ingredients are as safe and effective as products made to US spec.

Earlier this week, the Senate introduced a bill that would require the FDA to come up with a standard and process for approving -- I am not making this one up -- a safe cigarette.

Previously, Congress introduced a bill requiring the FDA to approve certain knock-off versions of biotech drugs as generic and as interchangeable without any safety tests or risk management or life cycle management strategies,

Previously still, legislation was introduced which required the FDA to set up a risk management program for every drug on the market and every new one being developed...except for imported drugs and generic biologics.

The FDA is still responsible for approving new medicines. I think.

But not until they improve spinach inspection and beef up labeling on peanut butter and organic foods.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog